Inc. NASDAQ GNVC

Related by string. Inc. Nasdaq GNVC * inc . INC. . INC . inc. . Incs . INCS : Inc. NASDAQ SCOR . Permissions Group Inc. . Treat Diseases Inc. . Limited Brands Inc. . SBC Communications Inc. . Resorts Worldwide Inc. / NASDAQ. . nasdaq . Nasdaq : NASDAQ OMX Group . Nasdaq Listing Qualifications . Apple Nasdaq AAPL . Motion RIM NASDAQ RIMM . NASDAQ / : GenVec NASDAQ GNVC . GenVec GNVC . Genvec Inc GNVC . GNVC * *

Related by context. Frequent words. (Click for all words.) 71 GNVC 71 Inc. NASDAQ VVUS 70 CYTX 70 ZGEN 69 NBIX 69 SGEN 69 VICL 69 RPRX 69 NASDAQ HGSI 69 DYAX 68 IMGN 68 EXAS 68 AUXL 68 SGMO 68 ALTH 68 NASDAQ DNDN 67 NASDAQ AMGN 67 INCY 67 Sunesis Pharmaceuticals Inc. 67 BPAX 67 AFFY 67 NASDAQ GILD 66 ALNY 66 GTXI 66 DCTH 66 VNDA 66 ISPH 65 BCRX 65 Inc. NASDAQ ALKS 65 Corporation NASDAQ GENZ 65 IMMU 65 MDVN 65 Calls Purchased 65 Idera Pharmaceuticals 65 GERN 65 NVAX 64 Nasdaq VRTX 64 SCLN 64 XNPT 64 Inc. NasdaqGM 64 Nasdaq DNDN 64 CLDA 64 POZN 64 NASDAQ CTIC 64 Ariad Pharmaceuticals 64 Inc. NASDAQ BIIB 64 Poniard Pharmaceuticals Inc. 64 MNTA 64 Bearish Pressure Building 64 BMTI 64 Rexahn Pharmaceuticals Inc. 64 Dynavax Technologies 63 NASDAQ STEM 63 Inc. Nasdaq NVAX 63 SVNT 63 Presents Positive 63 quotes/comstock/# * 63 PRXL 63 ONXX 63 VPHM 63 ACHN 63 Acadia Pharmaceuticals 63 Progenics Pharmaceuticals 63 Pluristem Therapeutics Inc. 62 Panacos Pharmaceuticals Inc. 62 KERX 62 XTL Biopharmaceuticals Ltd. 62 GNBT 62 ADVENTRX Pharmaceuticals Inc. 62 NASDAQ ARIA 62 QCOR 62 AVII 62 AKRX 62 MYGN 62 NASDAQ BPAX 62 Metabasis Therapeutics Inc. 62 BMRN 62 Interesting Options Volume 62 QGEN 62 NASDAQ CRXL 61 Idenix Pharmaceuticals 61 Guides FY# Quick Facts 61 SHARE ACTION 61 Options Trader Alert 61 Rexahn Pharmaceuticals 61 EPIX Pharmaceuticals Inc. 61 Q2 Loss Narrows 61 CYBX 61 Cyclacel Pharmaceuticals Inc. 61 AVNR 61 NovaBay Pharmaceuticals Inc. 61 MNKD 61 Oxigene 61 Lexicon Pharmaceuticals 61 Idenix Pharmaceuticals Inc. 61 SIGA Technologies Inc. 61 AEterna Zentaris Inc. 61 Q3 Loss Narrows 61 Human Genome Sciences HGSI 60 SHARES COULD POTENTIALLY PULLBACK 60 Skymark Research Initiates Independent

Back to home page